Safety and Efficacy Assessment of Trastuzumab Emtansine in Indian Patients With Human Epidermal Growth Factor Receptor 2‐Positive Unresectable Locally Advanced or Metastatic Breast Cancer Previously Treated With Trastuzumab and a Taxane: An Open‐Label, Single‐Arm, Phase IV Study

Sudeep Gupta, Manish Singhal, Shona Nag, Waseem Abbas, Dinesh Chandra Doval, Hari Goyal, Chirag Shah, Ashish Singh, Radheshyam Naik, Nitesh Rohatgi, Poonam Patil, Shyam Aggarwal, Vinod Raina, Vaibhav Watts

Open source

DOI: 10.1111/ajco.70007
Published: 2025-09-08
Container: Asia-Pacific Journal of Clinical Oncology
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/ajco.70007,
  title = {Safety and Efficacy Assessment of Trastuzumab Emtansine in Indian Patients With Human Epidermal Growth Factor Receptor 2‐Positive Unresectable Locally Advanced or Metastatic Breast Cancer Previously Treated With Trastuzumab and a Taxane: An Open‐Label, Single‐Arm, Phase IV Study},
  author = {Sudeep Gupta and Manish Singhal and Shona Nag and Waseem Abbas and Dinesh Chandra Doval and Hari Goyal and Chirag Shah and Ashish Singh and Radheshyam Naik and Nitesh Rohatgi and Poonam Patil and Shyam Aggarwal and Vinod Raina and Vaibhav Watts},
  year = {2025},
  journal = {Asia-Pacific Journal of Clinical Oncology},
  doi = {10.1111/ajco.70007},
  url = {https://doi.org/10.1111/ajco.70007}
}

RIS

TY  - JOUR
TI  - Safety and Efficacy Assessment of Trastuzumab Emtansine in Indian Patients With Human Epidermal Growth Factor Receptor 2‐Positive Unresectable Locally Advanced or Metastatic Breast Cancer Previously Treated With Trastuzumab and a Taxane: An Open‐Label, Single‐Arm, Phase IV Study
AU  - Sudeep Gupta
AU  - Manish Singhal
AU  - Shona Nag
AU  - Waseem Abbas
AU  - Dinesh Chandra Doval
AU  - Hari Goyal
AU  - Chirag Shah
AU  - Ashish Singh
AU  - Radheshyam Naik
AU  - Nitesh Rohatgi
AU  - Poonam Patil
AU  - Shyam Aggarwal
AU  - Vinod Raina
AU  - Vaibhav Watts
PY  - 2025
JO  - Asia-Pacific Journal of Clinical Oncology
DO  - 10.1111/ajco.70007
UR  - https://doi.org/10.1111/ajco.70007
ER  -

APA

Gupta, S., Singhal, M., Nag, S., Abbas, W., Doval, D. C., Goyal, H., Shah, C., Singh, A., Naik, R., Rohatgi, N., Patil, P., Aggarwal, S., Raina, V., & Watts, V. (2025). Safety and Efficacy Assessment of Trastuzumab Emtansine in Indian Patients With Human Epidermal Growth Factor Receptor 2‐Positive Unresectable Locally Advanced or Metastatic Breast Cancer Previously Treated With Trastuzumab and a Taxane: An Open‐Label, Single‐Arm, Phase IV Study. Asia-Pacific Journal of Clinical Oncology. https://doi.org/10.1111/ajco.70007

Source records

crossref · retrieved 2026-09-25T22:21:25.982Z